Dr. Lal Path Labs Ltd
Tata Mutual Fund trimmed its stake in Dr. Lal PathLabs from 1.41% to 1.39%, selling 26,864 shares.
A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.
AMC subsidiary of the Tata Group, India's most diversified conglomerate. Manages over Rs 1.8 lakh crore with a wide range of equity, debt and hybrid schemes. Part of the broader Tata Capital financial services ecosystem. Tata Small Cap Fund and Tata Digital India Fund have been among the most popular thematic and segment-specific equity offerings.